Vimarsana
Biggest News Aggregation in the World

Page 11 - Scott Struthers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Struthers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Struthers Today - Breaking & Trending Today

-$0.56 Earnings Per Share Expected for Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) This Quarter - Vimarsana News

-$0.56 Earnings Per Share Expected for Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) This Quarter

Wall Street analysts forecast that Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) will report ($0.56) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Crinetics Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.63) and the highest estimate coming in at ($0.44). Crinetics […]

Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer - Vimarsana News

Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer

Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace

Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer - Vimarsana News

Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer

SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare

Source: kulr8.com
Crinetics Pharmaceuticals : Appoints Caren Deardorf to Board of Directors - Vimarsana News

Crinetics Pharmaceuticals : Appoints Caren Deardorf to Board of Directors

SAN DIEGO - March 14, 2022 - Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for... | March 14, 2022

Crinetics Pharmaceuticals : Press Release dated March 14, 2022 - Form 8-K - Vimarsana News

Crinetics Pharmaceuticals : Press Release dated March 14, 2022 - Form 8-K

Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors SAN DIEGO, March 14, 2022 -- Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical... | March 14, 2022